View Financial HealthThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsHPX 배당 및 자사주 매입배당 기준 점검 0/6핵심 정보n/a배당 수익률133.3%자사주 매입 수익률총 주주 수익률133.3%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.공시 • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • May 29HPX Corp. Receives Notice from the NYSE Regarding Delayed Filing of Quarterly ReportOn April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange Commission (the “SEC”) together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (‘SPACs’)” (the “SEC Staff Statement”). As previously disclosed, given the scope of the process for determining the appropriate accounting treatment of its outstanding warrants in accordance with the SEC Staff Statement and Accounting Standards Codification (“ASC”) 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, HPX Corp. (the “Company”) was unable to complete and file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Form 10-Q”) by the required due date without unreasonable effort and expense. On May 25, 2021, HPX Corp. received a notice (the “Notice”) from the New York Stock Exchange (the “Exchange”) indicating that, as a result of not having timely filed the Form 10-Q with the SEC, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires listed companies to timely file all required periodic reports with the SEC. The Notice indicated that the Company can regain compliance with the Exchange’s listing standards at any time prior to November 24, 2021 by filing the Form 10-Q. If the Company fails to file the Form 10-Q by such date, the Exchange may grant, at its sole discretion, an extension for the Company to regain compliance, depending on the specific circumstances. The Notice also stated that the Exchange may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. While the Company can provide no assurances as to timing, the Company plans to file the Form 10-Q as soon as practicably possible, and no later than November 24, 2021, and regaining compliance with the Listing Rule.공시 • May 19HPX Corp. announced delayed 10-Q filingOn 05/18/2021, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Is New 90 Day High Low • Jan 26New 90-day high: US$10.61The company is up 10.0% from its price of US$9.65 on 27 October 2020. The American market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 24% over the same period.Is New 90 Day High Low • Jan 05New 90-day high: US$10.31The company is up 6.0% from its price of US$9.75 on 06 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 19% over the same period.Is New 90 Day High Low • Dec 14New 90-day high: US$9.98The company is up 1.0% from its price of US$9.85 on 14 September 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 16% over the same period.공시 • Dec 10Hpx Corp. Announces Board ChangesOn December 3, 2020, F bio Mour o informed HPX Corp. of his decision to resign from the board of directors of the company and as a member of the audit committee and chairman of the nominating and corporate governance committee, effective as of December 3, 2020. Mr. Mour o's resignation was voluntary and to pursue other professional endeavors and not the result of any disagreement with the operations, policies or practices of the company. Marcos Vinicius Bernardes Peigo, a director of the Company, was appointed to the audit committee in order to fill the seat left vacant by Mr. Mour o's departure. In addition, Mr. Peigo was appointed as the new chairman of the nominating and corporate governance committee.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 HPX 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: HPX 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장HPX 배당 수익률 vs 시장HPX의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (HPX)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.1%업계 평균 (Capital Markets)2.1%분석가 예측 (HPX) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 HPX 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 HPX 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 HPX 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: HPX 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/03/07 04:37종가2023/03/06 00:00수익2022/09/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스HPX Corp.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improves as stock rises 170%After last week's 170% share price gain to US$27.07, the stock trades at a trailing P/E ratio of 67.6x. Average trailing P/E is 28x in the Capital Markets industry in the US. Total returns to shareholders of 173% over the past year.
Board Change • Feb 14High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. CEO, CFO & Director Carlos Leone Piani is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Nov 15HPX Corp. announced delayed 10-Q filingOn 11/14/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 093GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction.3GA Participações S.A. entered into a business combination agreement to acquire HPX Corp. (NYSE:HPX) from HPX Capital Partners LLC and others in a reverse merger transaction on July 5, 2022. The combined company is expected to have a pro-forma enterprise value of approximately $581 million and a pro-forma implied market capitalization of approximately $798 million, assuming no redemptions from HPX Corp. shareholders. Upon closing of the Business Combination, Ambipar Emergency Response (“Ambipar Response”), a newly incorporated Cayman Islands exempted company that will hold the business of Emergência Participações S.A., is expected to become publicly listed on the NYSE under the ticker symbol “AMBI.” Ambipar Participações e Empreendimentos S.A. (“Ambipar Group”) (B3: AMBP3), currently the sole shareholder of Emergência Participações S.A., will remain a majority shareholder of Ambipar Response with an approximate 50% equity stake in Ambipar Response following the closing of the Business Combination and assuming no redemptions from HPX’s existing public shareholders, and up to 72% in case of total redemptions of HPX existing public shareholders. The economic ownership structure following the Business Combination is expected to be approximately: 50% Ambipar Group, 48% PIPE and HPX public shareholders, and 2% HPX sponsor. The consummation of the transactions contemplated by the Business Combination Agreement is subject to customary closing conditions, including approval by shareholders of HPX and Ambipar; HPX having at least $5,000,001 of net tangible assets; the receipt of approval for the New PubCo Class A Ordinary Shares to be listed on NYSE; delivery of the Contribution Agreement; HPX shall have at least $168,000,000 in cash and cash equivalents in the Trust Account; Parties will have received or have been deemed to have received all other necessary pre-Closing authorizations, consents, clearances, waivers and approvals of the Governmental Entities; The Registration Statement shall have become effective in accordance with the provisions of the Securities Act and other conditions. The Business Combination has been unanimously approved by the Board of Directors of Ambipar Group and HPX. Ambipar Participações e Empreendimentos S.A., shareholder of Emergência Participações S.A. also approved the merger agreement. Transaction is expected to close during the second half of 2022. Bank of America Merrill Lynch Banco Múltiplo S.A. is serving as financial advisor to Ambipar Response and Ambipar Group, and BofA Securities, Inc. is serving as the placement agent in connection with the PIPE offering. Mark Pflug and Grenfel Calheiros, Mark Brod, Tristan Brown, Lori Lesser, Mick Tuesley of Simpson Thacher & Bartlett LLP serving as U.S. legal advisors to Ambipar Response and Ambipar Group, and Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados is serving as Brazilian legal advisor to Ambipar Response and Ambipar Group. J. Mathias von Bernuth and Maxim Mayer-Cesiano of Skadden, Arps, Slate, Meagher & Flom LLP serving as U.S. legal advisors to HPX, Greenberg Traurig, LLP is serving as legal advisor on certain international diligence matters for HPX and BRZ Advogados as legal advisor on Brazilian matters. Shearman & Sterling LLP is acting as legal advisor to BofA Securities, Inc. in its capacity as the placement agent.
공시 • May 17HPX Corp. announced delayed 10-Q filingOn 05/16/2022, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01HPX Corp. announced delayed annual 10-K filingOn 03/31/2022, HPX Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • May 29HPX Corp. Receives Notice from the NYSE Regarding Delayed Filing of Quarterly ReportOn April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange Commission (the “SEC”) together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (‘SPACs’)” (the “SEC Staff Statement”). As previously disclosed, given the scope of the process for determining the appropriate accounting treatment of its outstanding warrants in accordance with the SEC Staff Statement and Accounting Standards Codification (“ASC”) 815-40, Derivatives and Hedging: Contracts in an Entities Own Equity, HPX Corp. (the “Company”) was unable to complete and file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Form 10-Q”) by the required due date without unreasonable effort and expense. On May 25, 2021, HPX Corp. received a notice (the “Notice”) from the New York Stock Exchange (the “Exchange”) indicating that, as a result of not having timely filed the Form 10-Q with the SEC, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual (the “Listing Rule”). The Listing Rule requires listed companies to timely file all required periodic reports with the SEC. The Notice indicated that the Company can regain compliance with the Exchange’s listing standards at any time prior to November 24, 2021 by filing the Form 10-Q. If the Company fails to file the Form 10-Q by such date, the Exchange may grant, at its sole discretion, an extension for the Company to regain compliance, depending on the specific circumstances. The Notice also stated that the Exchange may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. While the Company can provide no assurances as to timing, the Company plans to file the Form 10-Q as soon as practicably possible, and no later than November 24, 2021, and regaining compliance with the Listing Rule.
공시 • May 19HPX Corp. announced delayed 10-Q filingOn 05/18/2021, HPX Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Is New 90 Day High Low • Jan 26New 90-day high: US$10.61The company is up 10.0% from its price of US$9.65 on 27 October 2020. The American market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 24% over the same period.
Is New 90 Day High Low • Jan 05New 90-day high: US$10.31The company is up 6.0% from its price of US$9.75 on 06 October 2020. The American market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 19% over the same period.
Is New 90 Day High Low • Dec 14New 90-day high: US$9.98The company is up 1.0% from its price of US$9.85 on 14 September 2020. The American market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 16% over the same period.
공시 • Dec 10Hpx Corp. Announces Board ChangesOn December 3, 2020, F bio Mour o informed HPX Corp. of his decision to resign from the board of directors of the company and as a member of the audit committee and chairman of the nominating and corporate governance committee, effective as of December 3, 2020. Mr. Mour o's resignation was voluntary and to pursue other professional endeavors and not the result of any disagreement with the operations, policies or practices of the company. Marcos Vinicius Bernardes Peigo, a director of the Company, was appointed to the audit committee in order to fill the seat left vacant by Mr. Mour o's departure. In addition, Mr. Peigo was appointed as the new chairman of the nominating and corporate governance committee.